Transcript Slide 1

Newsletter 4th Edition October 2011.
Predicting 5-Aminosalicylate Nephrotoxicity in patients with
IBD
-an international IBD Genetics Consortium Project
Thank you to the sites who have recently recruited: Prof Hawkley, Nottingham; Dr Mansfield,
Newcastle; Dr Cooney, Birmingham; Dr Tremelling, Norwich; Dr Direkze, Frimley Park; Dr Muller, Kent;
Dr Simmons, Reading; Dr Quinlan, Bath; Dr Harbord, Chelsea; Dr Gore, Yeovil; Dr Chaudhary, West
Herts; Dr Dunckley, Gloucestershire; Dr Smith, Shrewsbury; Dr Soloman, Lancashire; Dr Hart, St
Mary’s. Highest recruiter so far – Dr Parkes, Cambridge with 4 patient!! Quickest time to recruit 1 st
Patient from site opening is Dr Vani, Mid Yorks
If you are having difficulties
locating baseline results
please call the team to
discuss.
01392 406928.
UK sites opened
in blue and
patients
recruited in red
PRED 4 will open in November looking
at 4 different drug side effects.
Thiopurine induced pancreatitis
Thiopurine induced
myelosuppression
Anti-TNF induced demyelination
PPI induced interstitial nephritis.
For further information please
contact Claire
If any identified precious
patients are reluctant to
participate due to pending
litigation please contact Claire.
There are 98 sites open to
recruitment. We would like it if all sites
(who have not already done so) could
have their 1st patient recruited by the
beginning of December 2011.
Dr Tariq Ahmad (CI). Email: [email protected].
Newsletter 3rd
Claire Bewshea Project Manager 01392 406928; Mobile: 07900 161244 or [email protected].:
Tracey
Hill Study
Coordinator;. 01392 406914; [email protected].
Edition
August
Dr Kenji So, Research Fellow and Co-investigator: Tel: 01392 402840; Mobile: 07760449147
2011
Please remember to fax in your recruitment logs